ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Introgen Therapeutics


Include trials that are no longer recruiting patients.

5 studies were found.
1.CompletedChemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer
Conditions: Male Breast Cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
2.RecruitingChemotherapy With or Without Gene Therapy in Treating Patients With Unresectable Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer
3.RecruitingComparison of Gene Therapy With Chemotherapy in Treating Patients With Head and Neck Cancer
Condition: Head and Neck Cancer
4.RecruitingEffectiveness and Safety of INGN 201 in Combination with Chemotherapy Versus Chemotherapy Alone
Condition: Carcinoma, Squamous Cell
5.RecruitingStudy to Compare the Overall Survival of Patients Receiving INGN 201 (study drug) with Patients Receiving Methotrexate
Condition: Carcinoma, Squamous Cell

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act